DNA-Based Non-Viral Technologies Market Size to Surpass USD

Source Domain: www.openpr.com

Market Projections: The global DNA-based non-viral technologies market is projected to grow from USD 6.57 billion in 2026 to USD 27.85 billion by 2035 with a CAGR of 17.40% during the forecast period.
Market Drivers: The rapid shift towards non-viral systems is driven by lower immunogenicity, repeat dosing capability, flexible manufacturing, and cost-efficient therapeutic development. Technologies like lipid nanoparticles, electroporation, polymer-based delivery systems, and nanoparticle-mediated systems are gaining prominence.
Key Growth Drivers: Major growth drivers are the rising demand for safer alternatives to viral vectors, expanding gene therapy pipelines, increased investments in biotechnology research, and the growth in personalized medicine.
Regional Insights: North America dominated the market with a 45% share in 2025, driven by strong investments in precision medicine. Asia Pacific is projected to have the highest growth rate, fueled by investments and infrastructure improvements.

You may have missed